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1. Introduction  
Coronary artery disease (CAD) is a major cause of mortality and morbidity and its 
management consumes a large proportion of national healthcare budgets (Underwood et al., 
2004). It has been estimated that approximately twenty diseases account for over 80% of all 
the deaths in the world (Satra et al., 2011). Specifically, atherosclerosis which occurs in the 
coronary arteries as the underlying defect responsible for CAD accounts for nearly half of 
these deaths. Although CAD treatment protocols are improving, its prevalence has 
increased. New imaging technologies have added to the immediate costs of investigation 
but they also have the potential to reduce overall costs, by virtue of their greater diagnostic 
and prognostic accuracy. This allows a more informed selection of therapy, which in turn can 
lead to a better clinical outcome (Underwood et al., 2004). 
Myocardial perfusion scintigraphy (MPS) was developed in the 1970s and has been used 
increasingly in clinical cardiology since the 1980s (Underwood et al., 2004). Technical 
developments that have fuelled this recent increase are single-photon emission tomographic 
computed imaging (SPECT), pharmacological stress and ECG-gated imaging (Underwood et al., 
2004). Nowadays, MPS comprises the only widely available method of assessing myocardial 
perfusion directly and many previously published reports support its evidence in the 
diagnosis of myocardial ischaemia and necrosis (Satra et al., 2011). Moreover, the prognostic 
value of this method for patients’ risk stratification has already been extensively reported, 
with an incremental prognostic value after clinical assessment, exercise electrocardiography 
and even above coronary angiography (Satra et al., 2011). Thus, MPS is an established 
imaging technique that is already an integral part of the management of CAD  (diagnosis, 
prognostication, selection for revascularization and assessment of acute coronary syndromes) 
and is included in a number of professional guidelines (Underwood et al., 2004).  
2. SPECT myocardial perfusion imaging agents 
MPS involves intravenous injection of small amounts of a radioactive tracer, usually during 
some form of cardiovascular stress. The three commercially available tracers are thallium-
201 thallous chloride (Tl-201), technetium-99m (Tc-99m) 2-methoxy-isobutyl-isonitrile 
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(MIBI) and technetium-99m 1,2-bis[bis(2-ethoxyethyl) phosphino] ethane (tetrofosmin). 
These are avidly extracted by cardiac myocytes and hence their initial myocardial 
distribution reflects a combination of the distribution of myocytes and perfusion. 
Comparison of images following stress and rest injections of tracer (or following 
redistribution for thallium) allows myocardial viability and perfusion to be assessed 
independently (Underwood et al., 2004). Tl-201 is a good tracer of myocardial perfusion and it 
has been used clinically for more than two decades (Hesse et al., 2005). It is administered 
intravenously as thallous chloride and the usual activity is 80 MBq. It does, however, have 
limitations: 
i. Relatively long physical half-life: high radiation burden for the patient (80 MBq delivers 
an effective dose of approximately 18 mSv). 
ii. Relatively low injected activity: low signal-to-noise ratio; images can be suboptimal 
(obese patients) and low count levels impair high-quality ECG-gated SPECT studies. 
iii. Relatively low energy emission: low-resolution images and significant attenuation by 
soft tissue. 
Tc-99m compounds do not have these limitations, which has encouraged the development 
and increasing use of such tracers, even if the physiological properties (somewhat lower 
fractional myocardial tracer uptake, in particular during high coronary flow values) of both 
Tc-99m labeled tracers are inferior to those of Tl-201 (Hesse et al., 2005). Two Tc-99m labeled 
perfusion tracers are currently available commercially: Tc-2-methoxyisobutylisonitrile (ses-
tamibi) and Tc-1,2-bis[bis(2-ethoxyethyl) phosphino] ethane (tetrofosmin). Tc-99m sestamibi 
is a cationic complex which diffuses passively through the capillary and cell membrane, al-
though less readily than Tl-201, resulting in lower immediate extraction. Within the cell it is 
localized in the mitochondria, where it is trapped (Li et al., 1990), and retention is based on 
intact mitochondria, reflecting viable myocytes. Elimination of the radiotracer occurs mostly 
through the kidneys and the hepatobiliary system. Tetrofosmin comprises an interesting 
alternative radiotracer for myocardial perfusion scanning, as it combines the exceptional 
physical properties of Tc-99m with easy and fast preparation. This compound is also cleared 
rapidly from the blood and its myocardial uptake is rather similar to that of sestamibi (Jain 
et al., 1993), with approximately 1.2% of the administered dose being taken up by the 
myocardium. The exact mechanism of uptake is unknown, but it is supposed to be similar to 
that of sestamibi. Elimination of the radiotracer occurs mostly through the kidneys and the 
hepatobiliary system, and the hepatic clearance is slightly more rapid than in the case of 
sestamibi (Münch et al., 1997). For both Tc-99m labeled tracers splanchnic uptake and 
excretion are markedly higher than for Tl-201, which may occasionally complicate 
interpretation of the inferior wall perfusion. The tracer molecules taken up by the cardiac 
myocytes remain within the cells: usually two visits on two different days are necessary to 
obtain optimal stress and rest images (Anagnostopoulos et al., 2003; Hesse et al., 2005). 
After intravenous injection, Tc-99m labeled radiopharmaceuticals are distributed within the 
myocardium according to myocardial perfusion and viability. Unlike Tl-201, they have little 
(sestamibi) or almost no redistribution (tetrofosmin) and so separate injections are required 
for stress and resting studies. The higher energy of Tc-99m generally leads to better quality 
images (because of less attenuation and scatter). Moreover, the short half-life of Tc-99m 
permits much higher activities to be administered, giving better counting statistics and thus 
allowing performance of left ventricular (LV) ECG gating or first-pass imaging, which 
provides additional functional information. The diagnostic reference level for tomography is 
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a total of 1000 MBq for a one-day protocol (normally divided as 250 MBq and 750 MBq), or 
400 MBq for each study of a two-day protocol. Higher activities can be considered on an 
individual basis by the practitioner, for instance in obese patients (Anagnostopoulos et al., 
2003; Hesse et al., 2005). 
3. Clinical evaluation of MPS 
Many studies have evaluated the diagnostic accuracy of MPS for the detection of coronary 
heart disease, but they are of variable size and quality. There is a wide range of values 
reported for sensitivity and specificity that tend to overlap between different tests, although 
there have been studies comparing these different protocols in a head-to-head fashion. In the 
largest single study of 2,560 patients randomized to each of the three tracers and using mainly 
adenosine stress (the ROBUST study), overall sensitivity in the subset of patients undergoing 
angiography was 91%, specificity 87% and normalcy rate 89%, with no significant difference 
between the three tracers (Kapur et al., 2002).  However, image quality was superior for the 
studies acquired with the Tc-99m-based agents, most likely due in part to the lower energy of Tl-
201. In contrast, there is generally good agreement between Tc-99m sestamibi and Tc-99m 
tetrofosmin in identifying myocardial ischaemia (Russell & Zaret, 2006). In one of our previous 
studies using Tc-99m tetrofosmin as the radiotracer, we have found a good segmental agreement 
between tetrofosmin scintigram and coronary angiography. The sensitivity, specificity, positive 
predictive value and negative predictive value ranged between 72.2-91.1%, 80.0-88.2%, 76.4-
88.5% and 83.3-85.7% respectively, depending on the obstructed vessel (Georgoulias et al., 1996). 
The power of myocardial perfusion imaging (MPI) for predicting future coronary events has 
been demonstrated in a large number of high-quality studies and in many thousands of pa-
tients. It is perhaps the area of nuclear cardiology where the evidence is most strong (Brown, 
1991, 1995, 1996). The most important variables that predict the likelihood of future events 
are the extent and severity of inducible ischaemia (Ladenheim et al., 1986) but other 
predictors are increased lung uptake of thallium (Gill et al., 1987), stress-induced ventricular 
dilatation (Weiss et al., 1987) and left ventricular ejection fraction (Gioia et al., 1996; Johnson 
et al., 1997). In general, markers of left ventricular dysfunction tend to predict cardiac 
mortality and inducible ischaemia predicts acute coronary syndromes (Hachamovitch et al., 
1998; Sharir et al., 2001). MPS has incremental prognostic value even after clinical 
assessment, exercise electrocardiography and coronary angiography (Iskandrian  et al., 1993; 
Sharir et al., 1999). In other words, patients who appear to be high risk after coronary 
angiography can be separated into higher and lower risk groups by MPS. In addition, 
several studies have indicated that a negative SPECT study confers an excellent prognosis 
with an annual cardiac event rate of <1% for the general population (Geleijnse  et al., 1996; 
Iskander & Iskandrian, 1998; Machecourt et al., 1994; Marie et al., 1995; Schinkel et al., 2005; 
Shaw et al., 2003). In the setting of a normal myocardial perfusion study in a low-risk 
patient, it takes 9 years for the risk of a cardiac event to reach 1%, suggesting that, in the 
absence of new symptoms, a repeat perfusion study may not be needed for 3 to 5 years 
(Russell & Zaret, 2006). However, this "warranty period" does not appear to be absolute and 
is affected by clinical and technical factors, including the presence of diabetes or CAD, 
increasing age and male gender, and the need to perform a pharmacologic stress test rather 
than an exercise perfusion imaging test, which can increase the annual cardiac event rate in 
patients with a normal perfusion scan to as high as 1.8% (Hachamovitch et al., 2003). In 
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these high-risk patients with normal myocardial perfusion studies, it may be prudent to 
perform repeat perfusion imaging on a more frequent basis.  
Because of its prognostic power, MPS can be used as the gatekeeper to coronary 
angiography. Bateman and colleagues showed that referral to coronary angiography after 
normal, mild to moderately abnormal and severely abnormal perfusion scans was 3.5%, 9% 
and 60% respectively (Bateman et al., 1995). Importantly, a policy of selective referral to 
coronary angiography based upon high-risk findings is defensible, as patients with mild to 
moderate abnormalities when managed medically have outcomes comparable to those 
undergoing invasive evaluation and subsequent revascularization (Underwood et al., 2004). 
Besides, several reports underlie that such a policy can be also cost-effective even if it is 
more expensive than an alternative test such as the exercise ECG (Underwood et al., 2004). 
Furthermore, MPS can provide useful information about cardiac risk in patients requiring 
non-cardiac surgery although these patients are generally at low risk and the predictive 
value of a normal perfusion study is greater than that of an abnormal study, while the 
clinical value of MPS using Tc-99m labeled agents (MIBI, tetrofosmin) to assess patients 
with acute coronary syndrome has been well established (Underwood et al., 2004).  
MPS is of proven value to assess patients post revascularization. Information gained from 
post-intervention  myocardial SPECT is important to differentiate patients with angina from 
those with exo-cardiac chest pain syndromes, to assess peri-intervention myocardial 
damage/acute vessel closure, to predict-detect restenosis after PCI and graft 
occlusion/stenosis after CABG surgery, to detect CAD progression in non-revascularized 
vessels, to assess left ventricular function (gated-SPECT), to evaluate the effects of 
intervention if required for occupational reasons and to predict patients’ long-term 
prognosis. With respect to detect graft patency, MPS has a 80-96% sensitivity and 61-88% 
specificity, while regarding restenosis after PCI, sensitivity and specificity range between 74-
94% and 67-88%, respectively (Georgoulias et al., 1998, 2008, 2010b). Specifically, using Tc-
99m tetrofosmin as the radiotracer, we  have reported a sensitivity, specificity, positive and 
negative  predictive value of MPI in detecting restenosis of 81.3%, 88%, 81.3% and 88%, 
respectively, whereas for the detection of restenosis in specific vessel, the corresponding 
values were 81.3%, 90%, 76.5% and 89.7%, respectively (Georgoulias et al., 1998, 2008, 
2010b). 
4. Increased pulmonary uptake during MPI 
It is generally supported that increased pulmonary uptake of a myocardial perfusion 
radiotracer reflects increased pulmonary capillary wedge pressure. This finding may be 
attributed to either ischaemic or non-ischaemic causes (valvular heart disease, 
cardiomyopathy, and pulmonary disease). 
4.1 Tl-201 pulmonary uptake 
A significant number of studies have engaged with the clinical importance of increased 
thallium (Tl)-201 lung uptake during myocardial perfusion imaging (Gill et al., 1987; 
Homma et al., 1987; Hurwitz et al., 1992; Kaul et al., 1998; Kurata et al., 1991; Liu et al., 1985; 
Mahmood et al., 1992). The quantification of lung uptake is mostly estimated using the 
lung/heart ratio (LHR) of radioactivity (counts/pixel) in two regions of interest (ROIs), one 
in the lung (usually the left one) and another one over the myocardium of the left ventricle, 
delineated in the anterior images (Gill et al., 1987; Hurwitz et al., 1992; Kurata et al., 1991; 
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Mahmood et al., 1992). However, there is a general discrepancy in the reported LHR normal 
values, depended mainly on the method of calculation. For Tl-201, LHR upper normal limits 
range in the literature from approximately 0.37 to 0.55 (Georgoulias et al., 2010a). Increased 
exercise Tl-201 uptake is associated with decreased left ventricular function, the presence of 
multiple-vessel CAD, and poor patient prognosis (Brown, 1997; Chin et al., 1996; Daou et al., 
2000; Gill et al., 1987; Kurata et al., 1991; Morel et al., 1999). Kurata et al. have found that 
patients with abnormal Tl-201 lung uptake had more extensive multiple-vessel CAD, more 
severe left ventricular dysfunction, and more perfusion defects than did patients with normal Tl-
201 pulmonary activity (Kurata et al., 1991).  
Follow-up studies have shown that abnormal lung Tl-201 uptake is in general a significant 
predictor of subsequent adverse cardiac events for patients undergoing an MPI. Moreover, 
the Tl-201 LHR prognostic value has been reported in specific subgroups such as in patients 
treated with thrombolytic therapy during acute myocardial infarction, in patients with 
unstable angina and non-Q myocardial infarction, in patients after coronary artery bypass 
grafting, in patients with left ventricular apical aneurysm and in patients with severe post-
ischaemic left ventricular dysfunction or after heart transplantation (Dakik et al., 1996; Jain 
et al., 1997; Krawczynska et al., 1997; Marcassa et al., 2000; Sarda et al., 2001;  Wu et al., 
2005). Abnormal pulmonary Tl-201 uptake during stress (treadmill or pharmacologic test) 
imaging has similar clinical significance to that noted during exercise. Thus, high uptake of 
Tl-201 in the lungs has an important prognostic value (Brown, 1997; Chin et al., 1996; Daou 
et al., 2000; Gill et al., 1987; Morel et al., 1999). Moreover, published data present an 
incremental prognostic value of increased Tl-201 pulmonary uptake over clinical, stress 
testing and other imaging findings, providing clinically useful risk assessment (Marcassa et 
al., 2000). 
4.2 Tc-99m sestamibi pulmonary uptake 
Although technetium-based radiopharmaceuticals have been widely used for several years, 
their limited use in lung uptake assessment has been regarded as a potential drawback. The 
results of assessing Tc-99m  sestamibi pulmonary-to heart ratio of activity on conventional 
images obtained 30–60 min after stress are ambiguous, while a few studies have suggested 
that measuring lung uptake of Tc-99m sestamibi on immediate post-stress images may be 
more valuable (Bacher-Stier et al., 2000; Choy & Leslie, 2001; Giubbini et al., 1995; Hurwitz 
et al., 1993; Hurwitz et al., 1996; Hurwitz et al., 1998; Hurwitz, 2000; Patel et al., 2004; 
Romanens et al., 2001; Saha et al., 1994). In addition, the methodology for calculating LHR 
among investigators varies; for example, a large ROI that enclosed the entire left ventricle or 
most of the left ventricle respectively and a fixed-size ROI in the left lung (Choy & Leslie, 
2001; Patel et al., 2004). Other widely used methods are the following: a transmural segment 
of the myocardium is outlined containing the area of peak counts and a crescenting ROI 
placed over the left lung or alternatively, a fixed small rectangular ROI placed over maximal 
myocardial and left lung activity (Hurwitz et al., 1993; Hurwitz et al., 1996; Hurwitz et al., 
1998; Hurwitz, 2000; Romanens et al., 2001). Thus, the reported LHR normal values for Tc-
99m sestamibi vary significantly between 0.44 and 0.56, depended on the method of 
calculation and the time interval between radiotracer’s injection and the acquisition of the 
image for the LHR calculation, although early post-stress calculated values are generally 
higher than those calculated during the standard acquisition time (Georgoulias et al., 2010a).  
In addition, conflicting results have been reported about the relation between the values of 
LHR measured in the delayed images and the presence of extensive myocardial ischaemia 
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or severe CAD (Bacher-Stier et al., 2000; Choy & Leslie, 2001; Patel et al., 2004; Saha et al., 
1994). On the other hand, the clinical value of Tc-99m sestamibi LHR obtained almost 
immediately after stress (exercise or vasodilatation), has been reported in several studies 
(Flamen et al., 1995; Münch et al., 1997; Nakajima et al., 1993). They have found that 
increased pulmonary to myocardial ratio calculated on early post-stress images was 
associated with severe scintigraphic abnormalities and angiographic findings (mainly three-
vessel disease or stenoses in the left mainstem), in concordance to Tl-201 post-stress lung 
uptake (Hurwitz et al., 1993; Hurwitz et al., 1998; Hurwitz, 2000; Romanens et al., 2001). In 
addition, Leslie et al. have reported the prognostic value of lung sestamibi uptake in a 
cohort of 718 patients with known or suspected CAD, who underwent a Tc-99m sestamibi 
MPI (Leslie et al., 2005). 
4.3 Tc-99m tetrofosmin pulmonary uptake 
As we have already mentioned Tc-99m tetrofosmin is an interesting alternative 
radiopharmaceutical for MPS, as it combines the exceptional physical properties of Tc-99m 
with easy and fast preparation (Georgoulias et al., 1996; Heo et al., 1994; Nakajima et al., 
1993; Sridhara et al., 1993). The diagnostic and prognostic value of myocardial perfusion 
SPECT studies using this radiotracer has already been well established, although a few 
studies have utilized the usefulness of lung uptake as an ancillary parameter. 
We have mentioned above the significant variability of the applied techniques for 
calculating LHR using Tc-99m labeled tracers. For the quantification of Tc-99m tetrofosmin 
pulmonary uptake, in our Nuclear Medicine Laboratory we acquire early anterior planar 
images (1000 kcounts, matrix 256X256), 4–6 min after radiotracer injection at stress (early 
post-stress images), considering that Tc-99m tetrofosmin has a rapid clearance from the 
lungs. We then delineate two ROIs: one square, 15X15 pixels, placed over the left mid-lung 
area at the vicinity of the myocardium (at a distance of at least 3 pixels above the 
anterolateral wall – ‘lung ROI’) and the other, manually drown irregular ROI, including the 
whole myocardial activity of the left ventricle (‘myocardial ROI’) (Choy & Leslie, 2001; 
Georgoulias et al., 2006; Patel et al., 2004) (Fig. 1). The pulmonary/heart ratio was 
determined as the mean counts/pixel in the lung ROI divided by the mean counts/pixel in 
the myocardial ROI (Choy & Leslie, 2001; Giubbini et al., 1995; Homma et al., 1987; Hurwitz 
et al., 1992; Hurwitz et al., 1998; Kaul et al., 1998; Kurata et al., 1991; Liu et al., 1985; Patel et 
al., 2004; Tanigaki et al., 1998; Tsou et al., 2002). Our method for calculating Tc-99m 
tetrofosmin LHR is similar to that used by Choy & Leslie (Choy & Leslie, 2001) and Patel et 
al. (Patel et al., 2004). This approach may underestimate the counts from the heart, if severe 
defects are present, thus potentially overestimating the LHR value. On the other hand, this 
method avoids problems related to hot spots or other artefacts that could have erroneous 
effects on LHR. We believe that our method is more representative of pulmonary and heart 
radioactivity, especially in cases with regional myocardial ischemia. 
The mechanism of lung uptake with Tc-99m labeled myocardial perfusion tracers has not 
been directly established, but it is reasonable to consider that it shares similarities with Tl-
201 lung uptake. Our findings (presenting below) that CAD severity, scintigraphic 
ischaemic abnormalities and clinical-exercise data of myocardial ischaemia have a 
considerable correlation with stress LHR, support the role of ischaemic left ventricular 
dysfunction with subsequent pulmonary congestion-increased pulmonary vascular transit 
time as previously suggested for thallium (although additional factors may be also 
important) (Choy & Leslie, 2001; Georgoulias et al., 2006).  
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RCA: right coronary artery; LCX: left circumflex artery; LAD: left anterior descending artery 
Fig. 1. (A) Normal early post-stress LHR value (0.402) in a 50-year-old woman without 
CAD. (B) Elevated early post-stress LHR value (0.693) in a 61-year-old man with 3-vessel 
disease (RCA 95%, LCX 95%, LAD 80%) (Reprinted from European Journal of Nuclear 
Medicine and Molecular Imaging, Vol. 37, Georgoulias, P., Tsougos, I., Valotassiou, V., 
Tzavara, C., Xaplanteris, P., & Demakopoulos, N., Long-term prognostic value of early 
poststress (99m)Tc-tetrofosmin lung uptake during exercise (SPECT) myocardial perfusion 
imaging, pp. 789-798, Fig. 1, 2010, with kind permission from Springer Science & Business 
Media B.V.). 
In 2006, we published our results of studying 158 consecutive patients who underwent a 
stress/rest Tc-99m tetrofosmin myocardial SPECT (rest scans were obtained as gated 
SPECT) and coronary angiography (Georgoulias et al., 2006). An early post-stress LHR 
value of 0.500 was defined as the upper normal limit, taking into consideration the early 
post-stress LHR values calculated in a normal group and using the formula ‘mean value ± 
2SD’. Patients with a normal early post-stress LHR value generally had a better performance 
in the treadmill testing than those with an abnormal value, had significantly better 
myocardial perfusion and function and better angiographic results (Georgoulias et al., 2006). 
We found a significant correlation (P <0.001) among early post stress LHR, summed stress 
score (SSS) and the number of stenosed vessels (Georgoulias et al., 2006). The associations 
between the values of early post-stress LHR and summed difference score (SDS), left 
ventricular ejection fraction (LVEF) were weaker (P= 0.031, P=0.017). The incidence of multi-
vessel CAD in the subgroup of patients with increased values of early post-stress LHR, was 
significantly higher than in the normal group (81% vs. 42%, P<0.001) (Georgoulias et al., 
2006). We also reported a significant difference (P<0.001) of the early post stress LHR value 
between patients with normal coronary arteries or one-vessel disease and patients with 
multi-vessel disease (Fig. 2). The above-mentioned data could be attributed to the influence 
of ischaemia on the early post-stress LHR value and are generally analogous with other 
published data, while other investigators did not find similar results using Tc-99m sestamibi 
as the radiotracer (Hurwitz et al., 1993; Hurwitz et al., 1998; Saha et al., 1994). 
Moreover, early post-stress LHR was an independent predictor of multi-vessel CAD 
(coefficient 1.85, SD 0.16, P<0.001), with an incremental value for its identification 
(Georgoulias et al., 2006). Similar results have been presented by Tsou et al., Tanigaki et al. 
and Okajima et al. who have also reported the incremental value of Tc-99m tetrofosmin 
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Fig. 2. Mean value (±SD) of early post-stress LHR, in patients with normal angiography, one-
vessel disease, two-vessel disease and three-vessel disease (Reprinted from Nuclear 
Medicine Communications, Vol. 27, Georgoulias, P., Demakopoulos, N., Kontos, A., 
Xaplanteris, P., Xydis, K., & Fezoylidis, I., Early post-stress pulmonary uptake of 99m Tc 
tetrofosmin during exercise (SPECT) myocardial perfusion imaging: correlation with 
haemodynamic, perfusion and function parameters, pp. 119-126, 2006, with kind permission 
from Wolters Kluwer Health). 
LHR, compared to conventional MPI, for the detection of multi-vessel disease (Okajima et 
al., 2004a; Tanigaki et al., 1998; Tsou et al., 2002). Specifically, the early post-stress LHR 
added incremental value to clinical, exercise testing, and myocardial perfusion and function 
data, for the identification of patients with multi-vessel CAD. In detail, if the cut-off point of 
early post-stress LHR value was set at 0.500, the sensitivity, positive and negative predictive 
value to detect multi-vessel CAD improved from 87%, 84% and 82% to 94%, 85% and 91%, 
respectively, while the specificity did not change considerably (78%) (Georgoulias et al., 
2006).  
On the other hand there are only few published data about the Tc-99m tetrofosmin LHR 
prognostic value (Casáns Tormo et al., 2001). In a previously published manuscript, we have 
evaluated the long-term prognostic value of early post-stress Tc-99m tetrofosmin LHR, in a 
cohort of 276 patients who were investigated with stress/rest Tc-99m tetrofosmin 
myocardial gated-SPECT (rest studies) and coronary angiography. During a mean follow-up 
period of 32.4 months (SD=9.6) hard cardiac events (cardiovascular death and non-fatal 
myocardial infarction) occurred in 28 (10.1%) patients and soft cardiac events 
(revascularization procedures) in 32 (11.6%) patients (Georgoulias et al., 2010a). Implying 
multiple Cox regression analysis with stepwise-forward approach, early post-stress LHR 
was found to be a significant independent predictor for both soft and hard cardiac events. 
The hazard ratio (for 0.1 unit increase) was 4.41 (95%CI: 1.52 - 12.73, p=0.006) for soft cardiac 
events and 4.22 (95%CI: 2.07 - 8.62, p<0.001) for hard cardiac events. The other significant 
prognostic factors were use of β-blockers, SSS and use of nitrates for soft events and exercise 
duration and SSS for hard cardiac events (Georgoulias et al., 2010a). 
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The cumulative soft event-free rates for one, two and five years were 100% (SE=0%), 99.2% 
(SE=0.8%) and 92.8% (SE=3.2%) for patients with early post-stress LHR value less than 0.500 
and 98.5% (SE=1.0%), 96.1% (SE=1.7%) and 63.5% (SE=5.8%) for patients with early post-
stress LHR value more than 0.500, respectively. Finally, the cumulative hard event-free rates 
for one, two and five years were 100% (SE=0%), 99.2% (SE=0.8%) and 89.8% (SE=3.7%) for 
patients with early post-stress LHR value less than 0.500 and 98.5% (SE=1.1%), 92.1% 
(SE=2.4%) and 75% (SE=5.0%) for patients with early post-stress LHR value more than 0.500, 
respectively (Fig. 3, 4). 
Furthermore, the incremental prognostic value of early post-stress LHR was evaluated by a 
statistically significant increase in the global chi-square of the Cox proportional-hazard 
model that included clinical, exercise, angiographic and scintigraphic variables (Valotassiou 
et al., 2009). Using ROC analysis, the optimal sensitivity and specificity of various early 
post-stress LHR cut-off values for the prediction of cardiac events, was determined. ROC 
curve analysis showed that the optimal cut-off of early post-stress LHR for the prediction of 
soft cardiac events was 0.527 with sensitivity equal to 78.1% and specificity equal to 80.7 
(Valotassiou et al., 2009). Similarly, the early post-stress LHR value of 0.530 represented the 
optimal cut-off for the prediction of hard cardiac events (sensitivity 68% and specificity 
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Fig. 3. Kaplan-Meier estimates for soft cardiac events according to early post-stress LHR 
levels (Reprinted from European Journal of Nuclear Medicine and Molecular Imaging, Vol. 
37, Georgoulias, P., Tsougos, I., Valotassiou, V., Tzavara, C., Xaplanteris, P., & 
Demakopoulos, N.,  Long-term prognostic value of early poststress (99m)Tc-tetrofosmin 
lung uptake during exercise (SPECT) myocardial perfusion imaging, pp. 789-798, Fig. 2, 
2010, with kind permission from Springer Science & Business Media B.V.). 
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78.6%). The area under the curve (AUC) was 0.80 (95% CI: 0.71 - 0.88) and 0.76 (95% CI: 0.66- 
0.86), for soft and hard cardiac events, respectively. The addition of early post-stress LHR in 
the Cox regression model, included clinical, exercise data and myocardial perfusion SSS, 
increased significantly the global chi-square for both soft and hard cardiac events (p<0.001) 
declaring the significant incremental value of early post-stress LHR. The adjusted hazard 
ratios for early post-stress LHR more than 0.53 were 9.44 and 7.51 (95% CI: 3.13 - 28.41, 
P<0.001) for soft and hard cardiac events, respectively (Valotassiou et al., 2009). 
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Fig. 4. Kaplan-Meier estimates for hard cardiac events according to early post-stress LHR 
levels (Reprinted from European Journal of Nuclear Medicine and Molecular Imaging, Vol. 
37, Georgoulias, P., Tsougos, I., Valotassiou, V., Tzavara, C., Xaplanteris, P., & 
Demakopoulos, N.,  Long-term prognostic value of early poststress (99m)Tc-tetrofosmin 
lung uptake during exercise (SPECT) myocardial perfusion imaging, pp. 789-798, Fig.3, 
2010, with kind permission from Springer Science & Business Media B.V.). 
To summarize, early post-stress Tc-99m tetrofosmin LHR appeared to be a useful index of 
extensive myocardial ischaemia, heart dysfunction and multi-vessel CAD (Georgoulias et 
al., 2006). Moreover, our results suggest that early post-stress LHR is an independent and 
powerful predictor for both hard (death or myocardial infarction) and soft cardiac events 
(revascularization procedures), providing incremental prognostic information to that 
provided by clinical, exercise testing and scintigraphic data (Georgoulias et al., 2010a; 
Valotassiou et al., 2009). In addition, an early post-stress LHR value of 0.53 was the optimal-
cut off for the prediction of any cardiac event and could be useful in clinical practice, 
contributing to more accurate patient risk stratification with valuable influence on their 
therapy (Valotassiou et al., 2009). 
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5. Incidental pathologic extra-cardiac findings during MPI 
Extra-cardiac findings during acquisition of MPS (using Tl-201 or Tc-99m labeled  
radiotracers) can be visualized in the area being viewed, including mainly the thorax and 
the upper abdomen, depending on the patient body size and the camera field of view (Kim 
et al., 2002; Vijayakumar et al., 2005). These extra-cardiac uptake accumulations may be 
benign or malignant and require further investigation which might be life saving for the 
patient (Kim et al., 2002; Vijayakumar et al., 2005). After intravenous administration, normal 
uptake of Tc-99m tetrofosmin is seen in several organs, most commonly localized in the 
heart, lungs, breasts mainly during lactation and lymph nodes, while in the abdomen 
significant normal uptake can occur in the liver, gall bladder and bowel (Vijayakumar et al., 
2005). Elimination of the radiotracer occurs mostly through the kidneys and the 
hepatobiliary system (Hesse et al., 2005). 
Pathologic uptake of Tc-99m tetrofosmin can occur in benign or malignant tumors and also 
in infectious or non-infectious diseases (Vijayakumar et al., 2005). The mechanism of uptake 
of Tc-99m tetrofosmin in non-cardiac lesions is not completely understood, but the size of 
the lesion, its mitochondrial-rich cellularity and perfusion (factors) play a significant role 
(Kinuya et al., 2003; Sükan et al., 2004). Over-expression of P-glycoprotein or multi-drug 
resistance can decrease tumor uptake and are also associated with resistance to cancer 
treatment. Benign Tc-99m tetrofosmin incidental extra-cardiac uptake in the neck and chest 
has been reported in thyroid diseases, parathyroid adenomas, benign lymph node 
hyperplasia, esophagitis, neurofibroma, smoker’s lung, lung infections, sarcoidosis and 
scapular hibernoma (Bestetti et al., 1996; Kannan et al., 2007; Oller et al., 2001; Vijayakumar 
et al., 2005). Photopenia in the lung bases due to pleural effusions and abnormal right liver 
configuration caused by elevation of the right hemi-diaphragm has also been reported 
during Tc-99m tetrofosmin MPS (Shih et al., 2002). In neck and chest malignant diseases, 
extra-cardiac uptake has been reported in: thyroid cancer, neuroendocrine tumors, 
mediastinal tumors, lung cancer, breast cancer, esophageal carcinoma, lymphoma, Kaposi’s 
sarcoma, multiple myeloma and in nasopharyngeal cancer (Khairallah et al., 2002; Okajima 
et al., 2004b; Torreggiani et al., 1999; Vijayakumar et al., 2005). Moreover, Tc-99m 
tetrofosmin incidental uptake in abdominal abnormalities has been detected during cardiac 
acquisition, when the area being viewed includes the lower thorax and the upper abdomen, 
in abnormalities of the liver, gallbladder, kidneys, oesophagus, stomach, bowel and bone 
marrow (Shih et al., 2002). Hepatocellular carcinoma, melanoma, sarcomas and multiple 
myeloma have also been described in the abdomen, accumulating Tc-99m tetrofosmin in 
MPS (Fisher et al., 2000; Hadase et al., 2003; Vijayakumar et al., 2005; Yi & Jacobs, 2004). 
Others, reviewing the raw data cine images of 566 patients during Tl-201 dipyridamole Tc-
99m tetrofosmin rest-stress MPS, found 234 abnormalities (Shih et al., 2002; Shih et al., 2005) 
such as: bone marrow visualisation (39.7%), duodenogastric and enterogastric reflux 
(20.1%), non-visualisation of the gallbladder (13.2%), small-atrophic-scarred, vaguely seen 
or ectopic kidneys, splenomegaly, liver diseases like hepatomegaly and cirrhosis and breast 
attenuation causing photopenia in the liver. The authors suggested that Tc-99m tetrofosmin 
is accumulated in the red bone marrow due to high and/or expanded haematopoetic 
activity. It is obvious that all these coincidental abdominal abnormalities should alert the 
referring physician to suggest further investigation. In addition, duodenogastric and 
enterogastric refluxes, which represent approximately 20% of the abdominal abnormalities, 
may cause symptoms mimicking angina. Recently, Gratz et al. reported six patients with 
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unexpected abnormal mediastinal and/or thoracic activities, out of 2155 who underwent  
Tc-99m tetrofosmin MPI. Subsequently, the patients underwent resection of a thymoma 
(n=2), nonsmall cell lung cancer (n=1) and breast cancer (n=3) (Gratz et al., 2008). 
We have previously published an unusual case of a 60 year-old woman with atypical 
precardiac symptoms who underwent Tc-99m tetrofosmin stress - rest SPECT imaging 
(Kotsalou et al., 2008). The MPI gated-study was normal. However, an incidental finding 
of intense extra-cardiac uptake of the radiotracer in the left paracardiac area was observed 
(Fig. 5).  
 
 
Fig. 5. Anterior (a) and left lateral (b) projections of the thorax, demonstrated intense Tc-99m 
tetrofosmin uptake in the left paracardiac area (arrows).  Myocardial perfusion SPET 
imaging was normal (c) (Reprinted from Hellenic Journal of Nuclear Medicine, Vol. 11, 
Kotsalou, I., Georgoulias, P., Fourlis, S., Zoumboulidis, A., Giaslakiotis, K., Androulaki, A., 
Chronopoulos, P., & Dimakopoulos, N.,  Incidental pathologic extracardiac uptake of 
99mTc-tetrofosmin in myocardial perfusion imaging, pp. 43-45, 2008, with kind permission 
from the Hellenic Society of Nuclear Medicine). 
The computerized tomography (CT) and magnetic resonance imaging (MRI) tests revealed a 
mass of 6 cm diameter in the left lower anterior mediastinal area (Fig. 6). The patient after a 
biopsy underwent surgical resection of the mass through medial sternotomy followed by 
adjuvant radiotherapy of the mediastinum, because of microscopic invasion of the capsule. 
The histologic-immunochistochemical examination established the diagnosis of a thymoma 
type AB and stage 2b (Masaoka II2 and TNM Pt2) (Fig. 7). 
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Fig. 6. Computed tomography (a) and magnetic resonance imaging (b) revealed a solid mass 
located in the left lower anterior mediastinal area, in contact but not infiltrating 
pericardium, while signs of pressing the left lung were also noticed (arrows).  Thymoma 
was the possible diagnosis (Reprinted from Hellenic Journal of Nuclear Medicine, Vol. 11, 
Kotsalou, I., Georgoulias, P., Fourlis, S., Zoumboulidis, A., Giaslakiotis, K., Androulaki, A., 
Chronopoulos, P., & Dimakopoulos, N.,  Incidental pathologic extracardiac uptake of 
99mTc-tetrofosmin in myocardial perfusion imaging, pp. 43-45, 2008, with kind permission 
from the Hellenic Society of Nuclear Medicine). 
Other authors have also reported cases of incidental thymoma detection during MPS 
(Chadika et al., 2005; Douglas et al., 2000; Rebollo Aguirre et al., 2003; Sciagrà et al., 1998; 
Vijayakumar et al., 2004; Vijayakumar et al., 2005). Moreover, Douglas et al. reviewed three 
cases of incidental occult thymoma, detected during dual isotope Tl-201 and Tc-99m 
tetrofosmin SPECT imaging (Douglas et al., 2000). The authors suggested that solitary extra-
cardiac uptake on Tc-99m images without Tl-201 uptake, corresponds to well- differentiated 
tumors, while the opposite corresponds to poorly-differentiated thymoma (Douglas et al., 
2000). 
6. Conclusion 
In conclusion, early post-stress Tc-99m tetrofosmin LHR has a significant clinical value, as a 
useful index of extensive myocardial ischaemia, heart dysfunction and multi-vessel CAD. 
Moreover, early post-stress LHR appears as an independent and powerful predictor, 
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Fig. 7. Histologic and immunochistochemical examination confirmed the diagnosis of a 
mixed type AB thymoma, stage Masaoka II2 and TNM Pt2 (Reprinted from Hellenic Journal 
of Nuclear Medicine, Vol. 11, Kotsalou, I., Georgoulias, P., Fourlis, S., Zoumboulidis, A., 
Giaslakiotis, K., Androulaki, A., Chronopoulos, P., & Dimakopoulos, N.,  Incidental 
pathologic extracardiac uptake of 99mTc-tetrofosmin in myocardial perfusion imaging, pp. 
43-45, 2008, with kind permission from the Hellenic Society of Nuclear Medicine). 
assigning incremental prognostic information to that provided by clinical, exercise testing 
and scintigraphic data. In addition, an LHR value of 0.53 was the optimal-cut off for the 
prediction of any cardiac event and could be useful in clinical practice. It seems that the 
clinical value of routine pulmonary uptake measurements during Tc-99m tetrofosmin 
myocardial scintigram, in immediate post-stress images, as an ancillary scintigraphic sign, 
will maximize not only the information it provides for the assessment of the severity of 
myocardial ischaemia and CAD, but also the prognostic value of the study. In an era where 
a continuous effort is underway for deriving as many elements as possible from the 
examinations, the calculation of early post-stress LHR during myocardial perfusion imaging 
may contribute to a better (more accurate) patient risk stratification with valuable influence 
on their therapy. 
Additionally, careful inspection of projection images should be an integral part of 
interpreting MPI studies. According to the literature, during Tc-99m tetrofosmin MPI 
various incidental extra-cardiac neck, chest and abdominal abnormalities have been 
detected. Even though MPI is performed for cardiac evaluation, Nuclear Medicine 
physicians should be aware of non-cardiac uptake of the radiotracer which can play an 
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essential role in early tumor detection resulting in life-saving early therapy. Any extra-
cardiac focal uptake of Tc-99m tetrofosmin requires attention of the interpreting physician 
and has to be mentioned in the report, guiding the referring physician to request further 
investigation. The identification of these coincidental findings is significant for the early 
detection of the coexisting pathology and may prove to be essential in saving patient’s life. 
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